Growth catalyst STARLIMS' rapid leadership changes and AI momentum indicate a strategic pivot toward laboratory automation and agentic AI capabilities, presenting a sales opportunity to offer AI-enabled LIMS, ELN, and automation integrations for highly regulated labs.

Acquisition synergies Recent Lonza MODA platform acquisition expands STARLIMS’ footprint in manufacturing operations and quality control; there is a sales opening to position integration services, data harmonization, and modauthoring capabilities to existing Lonza clients and CDMOs seeking end-to-end digital quality solutions.

Public health expansion The launch of STARLIMS life sciences for public health signals a growth vector into public health informatics and outbreak surveillance, offering opportunities to upsell repository, analytics, and epidemiology-focused modules to government, labs, and health agencies.

ROI validation ROI Calculator expansion emphasizes measurable savings from adopting STARLIMS R&D and manufacturing informatics, providing a compelling lead magnet for enterprise buyers; leverage this to generate targeted ROI-driven demonstrations and TCO analyses.

Global footprint With over 2,000 labs, 1,100+ customers across 85 countries and a diversified industry reach, target global accounts and multi-site enterprises for platform expansion, cross-sell of LIMS/ELN/SDMS/advanced analytics, and scalable deployments.